Search Results
Results found for "GPCR Drug Discovery"
- ⏳ In case you haven’t heard—registration for “Development of GPCR Ligands as Therapeutic Drugs” closes March 18th! If you’re working on GPCR drug discovery, you know that finding a promising candidate is just the start. A drug must also: ✅ Be absorbed into the body ✅ Reach the right target ✅ Stay long enough to be effective ✅ Cause no harm 📢 Spots are limited—register by March 18th! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery | Dr. GPCR Ecosystem
Drugs” closes March 18th! If you’re working on GPCR drug discovery, you know that finding a promising candidate is just the start 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. If you’re working on GPCR drug discovery , you know that finding a promising candidate is just the start 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr.
- 📢 All 2025 Dr.GPCR Courses Are Open for Registration! Which one will you choose? 🚀 Whether you're diving into GPCR drug discovery, pharmacology, or advanced modeling, there's a course for you. 💡 Bonus: Premium Members enjoy 25% off on all courses! 🔗 Explore & register today: https://www.ecosystem.drgpcr.com/gpcr-courses #GPCR #DrGPCR #Biotech #DrugDiscovery #Pharmacology | Dr. GPCR Ecosystem
🚀 Whether you're diving into GPCR drug discovery, pharmacology, or advanced modeling, there's a course 🔗 Explore & register today: https://www.ecosystem.drgpcr.com/gpcr-courses #GPCR #DrGPCR #Biotech #DrugDiscovery #Pharmacology Published on March 4, 2025 Category GPCR Weekly News 📢 All 2025 Dr.GPCR Courses Are Open 🚀 Whether you're diving into GPCR drug discovery, pharmacology, or advanced modeling, there's a course 🔗 Explore & register today: https://www.ecosystem.drgpcr.com/gpcr-courses #GPCR #DrGPCR #Biotech #DrugDiscovery
- “Research is all about knowing when to walk and when to run.” –Ben Clements In Ep. 166 of the Dr.GPCR Podcast, hear how a postdoc is reshaping the conversation on opioid use, imposter syndrome, and the power of collaborative science. Why early-career voices are critical in GPCR drug discovery —and how lab culture makes all the difference. 🎧 Watch here: https://buff.ly/Kr3qKud #GPCRresearch #DrGPCR #GPCRpodcast #OpioidPharmacology #DrugDiscovery | Dr. GPCR Ecosystem
Why early-career voices are critical in GPCR drug discovery —and how lab culture makes all the difference GPCR Podcast “Research is all about knowing when to walk and when to run.” Why early-career voices are critical in GPCR drug discovery —and how lab culture makes all the difference
- 🚀 New Workshop: Practical Quantification of Allosteric Modulation Join Dr. Terry Kenakin on May 1st, 2025, for an advanced live workshop on allosteric modulators in GPCR drug discovery. Learn how to: ✔️ Identify, measure, and quantify allosteric properties ✔️ Apply functional allosteric models to determine mechanisms of action ✔️ Confirm allostery through kinetic analysis 📅 Date: May 1st, 2025 ⏳ Registration deadline: April 18th 📍 Live on Google Meet 🔗 Register now: https://www.ecosystem.drgpcr.com/event-details-registration/practical-quantification-of-allosteric-modulation #GPCR #Allostery #DrugDiscovery #Pharmacology | Dr. GPCR Ecosystem
Terry Kenakin on May 1st, 2025, for an advanced live workshop on allosteric modulators in GPCR drug discovery www.ecosystem.drgpcr.com/event-details-registration/practical-quantification-of-allosteric-modulation #GPCR #Allostery #DrugDiscovery #Pharmacology Published on March 3, 2025 Category GPCR University 🚀 New Workshop Terry Kenakin on May 1st, 2025 , for an advanced live workshop on allosteric modulators in GPCR drug discovery.
- ep 175 with jens carlsson clip 2 | Dr. GPCR Ecosystem
Discover how strategic collaboration drives real GPCR drug discovery impact. GPCR Podcast If your model can’t change an experiment, what’s the point? That’s the standard Dr. In GPCR drug discovery, where complexity is the rule and timelines are tight, this kind of cross-functional GPCR Podcast: model predict discover #DrGPCR #GPCR #CollaborationInScience #ComputationalChemistry #Pharmacology
- ⚠️ Registration Deadline today! This is your last chance to register for Principles of Pharmacology II - Advanced Methods for the Optimization of Candidate Selection with Dr. Terry Kenakin. Learn more about new ligands and new GPCR behaviors that produce unique drug profiles. | Dr. GPCR Ecosystem
GPCR to expand fluorescent ligand tools for GPCR drug discovery, connecting biotech startups and scientists Learn more about new ligands and new GPCR behaviors that produce unique drug profiles. GPCR Courses ⚠️ Registration Deadline today! Learn more about new ligands and new GPCR behaviors that produce unique drug profiles. ✳️ Last chance https://www.ecosystem.drgpcr.com/advanced-methods-for-the-optimization-of-candidate-selection #gpcr #
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Expert support, trusted CROs, and ready-to-use tools to accelerate GPCR drug discovery, reduce risk, GPCR Foundry: Accelerate GPCR Drug Discovery Move from idea to insight—faster, smarter, and with confidence GPCR Foundry is a nonprofit platform designed to help biotech leaders accelerate GPCR drug discovery Book Plan Your Next Move in GPCR Discovery Meet directly with Dr. Let's move your GPCR discovery program forward.
- ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem
Jens Carlsson’s lab at Uppsala University is redefining GPCR drug discovery with predictive molecular Jens Carlsson and his team are redefining what computational modeling means in drug discovery. drug discovery. 🎧 Explore how predictive modeling is reshaping GPCR science in this Dr. discovery often assumes receptor inhibition follows simple rules—agonist binds, antagonist blocks, and GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase
- Past Events by Dr. GPCR Ecosystem
together to share groundbreaking discoveries, spark new ideas, and forge lasting connections. Be part of our journey — stay inspired by our collective passion for science, learning, and discovery GPCR: Advancing GPCR Drug Discovery Through Collaboration Discovery On Target 2024 GPCR targeted drug discovery Summit 2024 GPCR targeted drug discovery Summit 2023 The Dr. GPCR Podcast GPCR targeted drug discovery Summit 2022 Dr.
- master gpcr pharmacologic models before its too late | Dr. GPCR Ecosystem
Home → Flash News → master gpcr pharmacologic models before its too late Published on July 11, 2025 Category GPCR Weekly News Most GPCR teams aren’t failing because of bad science. This week’s GPCR Weekly News helps you fix that. Yamina’s Corner exposes the silent drift killing GPCR programs (and how to reverse it). ✳️ Read the Weekly News → https://www.ecosystem.drgpcr.com/post/crush-data-confusion-conquer-gpcr-drug-discovery
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
GPCR Podcast Strategic Partners Dr. GPCR podcast , your host and founder, Dr. GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well , grow, and thrive together to accelerate GPCR drug discovery and improve human health. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through GPCR Ecosystem We unite the GPCR community to advance drug discovery. We bring the GPCR community together to fuel GPCR drug discovery—one receptor at a time. Contact Us Our Mission Advance GPCR science and drug discovery by connecting people, data, and opportunities across the global GPCR ecosystem.
- Dr. GPCR | Explore the Ecosystem for GPCR Professionals and Enthusiasts
Home: About Accelerating GPCR Drug Discovery, Together Dr. GPCR is the global hub where academia and industry meet to advance GPCR research, accelerate drug discovery How a Failed Experiment Created a Powerful GPCR Imaging Tool From Farm Fields to GPCR Discovery, GLP the GPCR field through shared knowledge, collaboration, and open access to tools that accelerate drug knowledge, collaboration, and open access to tools that accelerate drug discovery. 🤝 Support the Mission
- ama session sept 18 post 2 | Dr. GPCR Ecosystem
Terry’s Corner AMA distills advanced GPCR insights into clear, practical frameworks for drug discovery Home → Flash News → ama session sept 18 post 2 What happens when 40+ years of discovery experience get Published on October 29, 2025 Category Terry's Corner What happens when 40+ years of discovery experience Through live Q&A, targeted modules, and short, focused lessons, Terry’s Corner gives discovery teams It’s an open vault of knowledge. 🟢 Read More → https://www.ecosystem.drgpcr.com/post/accelerating-gpcr-drug-discovery-what
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
GPCR Podcast Strategic Partners Dr. Yamina Berchiche About Dr. Yamina Berchiche Dr. Yamina A. (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR podcast. Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- Yamina's Corner | Dr. GPCR Ecosystem
Turn GPCR discovery chaos into clarity—Yamina’s Corner offers expert GPCR strategy, CRO guidance, and Power Discovery How We Work: Your Path to GPCR Success 1 Initial Strategic Alignment We begin with a drug discovery. Berchiche, and I understand the intricate challenges of GPCR drug discovery. drug discovery.
- Inês Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem
As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and adhesion GPCRs. (GPCRs), that control virtually everything in the body, as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- GPCR Weekly News | Dr. GPCR Ecosystem
you connected to the discoveries and opportunities that matter most. Latest Research Breakthrough discoveries, new publications, and cutting-edge GPCR research insights. Week in GPCRs Read Full Issue November 14 - 20, 2025 Crafting Chemical Keys for GPCR Drug Discovery GPCR Read Full Issue Oct 24 - Nov 6, 2025 The Power and Peril of Irreversible Drugs Read Full Issue Oct research and drug discovery.
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
GPCR Podcast Strategic Partners Visualizing GLP-1 & GIP Receptors in Islets and Brain In this episode drug discovery . Why this matters How receptor distribution in islets and brain circuits shapes incretin hormone drug assays Worked across disciplines where chemistry, pharmacology, and physiology converge Questioned how drug GPCR Podcast? Leave a Review.
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
at the bench and in translational drug discovery. discovery assays. Pivoting: From Chemistry Company to Discovery Partner Initially focused on tool production, Celtarys Whether you're designing assays, developing probes, or seeking better tools for GPCR drug discovery, GPCR ecosystem , GPCR drug discovery , fluorescent ligands , GPCR scientist network , custom ligand development
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
His journey highlights the transition from general drug development to a deep dive into G protein-coupled Allosteric Modulation: The New Frontier of GPCR Drug Discovery Ben reflects on the emerging potential Translating Discovery into Therapy: Bench to Bedside Vision Ben’s work seeks to merge in vitro mechanistic “The goal is to smash all the amazing biology together and make a drug.” GPCR ecosystem , GPCR online course , GPCR scientist network , GPCR drug discovery , GPCR training program
- Dr. GPCR Team | Dr. GPCR Ecosystem
(GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery discovery program.
- Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem
“I got to know computational chemistry through a project on BCL2 proteins and drug discovery… I was in drug discovery pipelines. By bridging structural prediction, molecular dynamics, and ligand discovery, his work not only deciphers GPCR ecosystem , GPCR online course , GPCR scientist network , GPCR drug discovery , GPCR training program leveraging computational structure-based tools and develop specific protocols to accelerate OR ligand discovery
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
function The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Stephanie Häfner and Pharmacology-Enabling Drug Discovery Laurent Sabbagh Characterizing hADGRE5/CD97 Activation and Discovery for Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are drug discovery methods. bowel disease and small molecules drug discovery for polycystic kidney disease.
- Our History | Dr. GPCR Ecosystem
Featured Appearances Aug 2020 — Featured on 17 Minutes of Science with Advancing GPCR Drug Discovery Mar 2022 — Media Partner at GPCR Targeted Drug Discovery Summit . Feb 2023 — Media Partner at GPCR Targeted Drug Discovery Summit . Community Engagement Mar 2024 — Media Partner at 3rd GPCR Targeted Drug Discovery Summit . Oct 2024 — Media Partner at Discovery on Target .
- VC Insights | Dr. GPCR Ecosystem
drug discovery. Fast Track My Discovery The wrong CRO—or wrong experiments—can burn months and millions You're not here Chat about My Discovery Send me a message First name* Last name Company name* Email* How Can I Help? Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution GPCR Corp Proudly created with Wix.com
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
drugs. pharmacologist—led her to investigate how these drugs shut down breathing in different ways. Who Should Listen This episode is especially relevant for: GPCR drug discovery scientists Respiratory master’s in pharmacogenomics at Manchester University, igniting her fascination with how genetics and drugs GPCR ecosystem , GPCR training program , GPCR podcast , opioid pharmacology , xylazine research , mu
- GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem
Falling in Love with GPCRs GPCR pharmacology captured his scientific curiosity. GPCR ecosystem , GPCR scientist network , GPCR drug discovery , GPCR training program , GPCR online course , G protein-coupled receptors , GPCR podcast , GPCR webinar series , GPCR data platform Summary created by AI ________ About Sokhom Pin Sokhom Pin is a receptor pharmacologist with over 20 years of drug discovery He is passionate about mechanistic profiling of therapeutic molecules as well as drug discovery in general
- GPCR Courses | Dr. GPCR Ecosystem
Stay at the Forefront of GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling research Access exclusive training from the scientists shaping the future of GPCR drug discovery Dr. Think of Premium as insurance against wasted experiments and failed drug leads. Aside from his vast experience in drug development, not to mention his extensive publication record, The GPCR Field Is Advancing Fast – Don't Fall Behind Stay ahead in drug discovery with insights from
- Celtarys Research | Dr. GPCR Ecosystem
Explore their innovative GPCR projects, collaborations, and contributions to cutting-edge drug discovery innovative fluorescent probes that de-risk the pre-clinical drug discovery phase. Celtarys News & Updates Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies Choosing the right fluorescent tools is important for the success of drug discovery, just as much as choosing the drug discovery, starting from hit and lead validation all the way to pre-clinical assays.












